Main content area

Expression of RANTES mRNA in skin lesions of feline eosinophilic plaque

Kimura, Tomoe, Kano, Rui, Maeda, Sadatoshi, Tsujimoto, Hajime, Nagata, Masahiko, Hasegawa, Atsuhiko
Veterinary dermatology 2003 v.14 no.5 pp. 269-273
amino acid sequences, amino acids, cats, cattle, chemoattractants, chemokine CCL5, chemotaxis, complementary DNA, eosinophils, genes, humans, messenger RNA, mice, molecular cloning, mucosa, open reading frames, reverse transcriptase polymerase chain reaction, sequence analysis, skin lesions, veterinary medicine
One of the mechanisms of eosinophil infiltration is its induction by chemoattractants such as regulated upon activation, normal T-expressed and secreted (RANTES) which is a cysteine–cysteine chemokine that mediates chemotaxis and activation of eosinophils in humans and mice. Skin lesions of feline eosinophilic plaque are characterized by a predominant infiltration of eosinophils. The mechanism(s) of eosinophilic infiltration in the skin and/or mucosa of cats is unknown. It is possible that RANTES is involved. To investigate the presence of RANTES in the skin of cats with eosinophilic plaques and nonaffected skin, we cloned and sequenced the full-length feline RANTES cDNA gene, in order to determine whether it is present in the skin of cats with eosinophilic plaques and/or if it is present in normal adjacent skin. We were able to document the the expression of RANTES mRNAs in skin with feline eosinophilic plaque as well as in normal cat skin. The full-length cDNA sequence of the RANTES gene (742 bp) contained a single open reading frame of 276 bp encoding a protein of 92 amino acids. The amino acid sequence of feline RANTES shared 67 and 74% sequence identity with that of bovine and mouse RANTES genes, respectively. RT–PCR analysis on RANTES mRNA in the skin of cats with eosinophilic plaque revealed that its expression was higher in the eosinophilic plaque skin lesions than in the normal skin. The result suggested that RANTES might play a role to induce eosinophil infiltration in feline eosinophilic plaque lesions.